Angiotensin II Type 1 Receptor A1166C Polymorphism and Prophylactic Indomethacin Treatment Induced Ductus Arteriosus Closure in Very Low Birth Weight Neonates

Pediatric Research

Volumn 54, Issue 5, 2003, Pages 753-755

  Treszl, András ^a   Szabó, Miklós ^a   Dunai, György ^a   Nobilis, András ^a   Kocsis, István ^a   Machay, Tamás ^a   Tulassay, Tivadar ^a   Vásárhelyi, Barna ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b First Department of Pediatrics   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; INDOMETACIN;

ARTICLE; BIRTH WEIGHT; DUCTUS ARTERIOSUS OBLITERATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HYPOTENSION; INFANT; LOGISTIC REGRESSION ANALYSIS; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; PATENT DUCTUS ARTERIOSUS; POSTNATAL CARE; PRIORITY JOURNAL; PROPHYLAXIS; RESPIRATORY DISTRESS; VASOCONSTRICTION; VERY LOW BIRTH WEIGHT;

CARDIOVASCULAR AGENTS; DUCTUS ARTERIOSUS, PATENT; FEMALE; GENOTYPE; GESTATIONAL AGE; HUMANS; INDOMETHACIN; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; POLYMORPHISM, GENETIC; PREGNANCY; RECEPTOR, ANGIOTENSIN, TYPE 1; RETROSPECTIVE STUDIES;

EID: 0142148058     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.PDR.0000088016.67117.39     Document Type: Article

References (17)

1. Cargill RI, Lipworth BJ 1995 The role of the renin-angiotensin and natriuretic peptide systems in the pulmonary vasculature. Br J Clin Pharmacol 40:11-18
2. Lipworth BJ, Dagg KD 1994 Vasoconstrictor effects of angiotensin II on the pulmonary vascular bed. Chest 105:1360-1364
3. Tan LM, Sim MK 2000 Actions of angiotensin peptides on the rabbit pulmonary artery. Life Sci 66:1839-1847
4. Kaye AD, Nossaman BD, Smith DE, Ibrahim IN, Anwar M, Kadowitz PJ 1998 Analysis of responses to angiotensin I (3-10) and Leu3 angiotensin (3-8) in the pulmonary vascular bed of the cat. Am J Ther 5:295-302
5. Morrell NW, Upton PD, Higham MA, Yacoub MH, Polak JM, Wharton J 1998 Angiotensin II stimulates proliferation of human pulmonary artery smooth muscle cells via the AT1 receptor. Chest 114(suppl):90S-91S
6. Kiely DG, Cargill RI, Wheeldon NM, Coutie WJ, Lipworth BJ 1997 Haemodynamic and endocrine effects of type 1 angiotensin II receptor blockade in patients with hypoxaemic cor pulmonale. Cardiovasc Res 33:201-208
7. Clair MJ, Krombach RS, Hendrick JW, Houck WV, Hebbar L, Kribbs SB, Rios G, Whitebread S, Mukherjee R, de Gasparo M, Spinale FG 1998 AT1 angiotensin II receptor inhibition in pacing-induced heart failure: effects on left ventricular performance and regional blood flow patterns. J Card Fail 4:311-323
8. Duncan JA, Scholey JW, Miller JA 2001 Angiotensin II type 1 receptor gene polymorphisms in humans: physiology and pathophysiology of the genotypes. Curr Opin Nephrol Hypertens 10:111-116
9. Hingorani AD, Jia H, Stevens PA, Hopper R, Dickerson JE, Brown MJ 1995 Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin-converting enzyme inhibition. J Hypertens 13:1602-1609
10. Kainulainen K, Perola M, Terwilliger J, Kaprio J, Koskenvuo M, Syvanen AC, Vartiainen E, Peltonen L, Kontula K 1999 Evidence for involvement of the type 1 angiotensin II receptor locus in essential hypertension. Hypertension 33:844-849
11. Kluckow M, Evans N 2000 Ductal shunting, high pulmonary blood flow, and pulmonary hemorrhage. J Pediatr 137:68-72
12. Modi N 1999 Disorders of the kidney and urinary tract. In: Rennie JM, Roberton NRC (eds): Textbook of Neonatology. Churchill-Livingston, Edinburgh, pp 1009-1037
13. Szalai C, Czinner A, Révai K 1996 The frequency of medium-chain acyl-CoA dehydrogenase G985 mutation in the Hungarian population. Eur J Pediatr 155:256
14. Szombathy T, Jánoskúti L, Szalai C, Császár A, Miklósi M, Mészáros Z, Kempler P, László Z, Fenyvesi T, Romics L 2000 AII type 1 receptor gene polymorphism and mitral valve prolapse syndrome. Am Heart J 139:101-105
15. Krombach RS, Clair MJ, Hendrick JW, Houck WV, Zellner JL, Kribbs SB, Whitebread S, Mukherjee R, de Gasparo M, Spinale FG 1998 Angiotensin-converting enzyme inhibition, AT1 receptor inhibition, and combination therapy with pacing-induced heart failure: effects on left ventricular performance and regional blood flow patterns. Cardiovasc Res 38:631-645
16. Barr M 1994 Teratogen update: angiotensin-converting enzyme inhibitors. Teratology 50:399-409
17. Miller JA, Thai K, Scholey JW 1999 Angiotensin II type 1 receptor gene polymorphism predicts response to losartan and angiotensin II. Kidney Int 56:2173-2180